Fort, L.P.
- SEC CIK
- 0001633517
- Latest filing
- Oct 29, 2024
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Fort, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q3 2024 holdings
- Shares (Q3 2024)
- 257
- Value
- $270.2K
- % of portfolio
- 0.7%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 257 | $270.2K | 0.7% | −31−10.8% | Reduced | Holders |
| Q2 2024 | 288 | $302.7K | 0.8% | +3+1.1% | Added | Holders |
| Q1 2024 | 285 | $274.3K | 0.7% | −38−11.8% | Reduced | Holders |
| Q4 2023 | 323 | $283.7K | 0.7% | −25−7.2% | Reduced | Holders |
| Q3 2023 | 348 | $286.4K | 0.8% | −20−5.4% | Reduced | Holders |
| Q2 2023 | 368 | $264.4K | 0.7% | −49−11.8% | Reduced | Holders |
| Q1 2023 | 417 | $342.6K | 0.9% | −197−32.1% | Reduced | Holders |
| Q4 2022 | 614 | $443.0K | 0.7% | −101−14.1% | Reduced | Holders |
| Q3 2022 | 715 | $493.0K | 0.6% | −207−22.5% | Reduced | Holders |
| Q2 2022 | 922 | $545.0K | 0.4% | +47+5.4% | Added | Holders |
| Q1 2022 | 875 | $611.0K | 0.2% | +256+41.4% | Added | Holders |
| Q4 2021 | 619 | $391.0K | 0.1% | −488−44.1% | Reduced | Holders |
| Q3 2021 | 1,107 | $670.0K | 0.2% | −698−38.7% | Reduced | Holders |
| Q2 2021 | 1,805 | $1.01M | 0.3% | −866−32.4% | Reduced | Holders |
| Q1 2021 | 2,671 | $1.26M | 0.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.